{"disease":{"id":"lymphopenia","name":"lymphopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04800731","title":"Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":227,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT06968156","title":"The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Kanuni Sultan Suleyman Training and Research Hospital","has_results":false},{"nct_id":"NCT06368349","title":"Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04404608","title":"Etiology of Lymphopenia in Covid19 Infection","phase":"","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Dr Medhat Khafagy","has_results":false},{"nct_id":"NCT05889169","title":"Stroke-induced Immunodepression in Neurorehabilitation","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"IRCCS National Neurological Institute \"C. Mondino\" Foundation","has_results":false},{"nct_id":"NCT06181656","title":"Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07267234","title":"PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":65,"lead_sponsor_name":"Second Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05600920","title":"A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04910230","title":"Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Qiang Hu","has_results":false},{"nct_id":"NCT07492888","title":"Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"ImmunityBio, Inc.","has_results":false},{"nct_id":"NCT04097561","title":"Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02659800","title":"Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT07492875","title":"Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"ImmunityBio, Inc.","has_results":false},{"nct_id":"NCT04874818","title":"CD8+ T-cell PET/CT Imaging in COVID-19 Patients","phase":"","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT06956547","title":"Expanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Count (ALC) for the Treatment of Lymphopenia Induced by Chemotherapy, Immunotherapy, and/or Radiation Therapy","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"ImmunityBio, Inc.","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}